FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 339:229-234 July 23, 1998 Number 4 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Type 2 (non-insulin-dependent) diabetes is associated with a marked increase in the risk of coronary heart disease. It has been debated whether patients with diabetes who have not had myocardial infarctions should be treated as aggressively for cardiovascular risk factors as patients who have had myocardial infarctions.

Methods To address this issue, we compared the seven-year incidence of myocardial infarction (fatal and nonfatal) among 1373 nondiabetic subjects with the incidence among 1059 diabetic subjects, all from a Finnish population-based study.

Results The seven-year incidence rates of myocardial infarction in nondiabetic subjects with and without prior myocardial infarction at base line were 18.8 percent and 3.5 percent, respectively (P<0.001). The seven-year incidence rates of myocardial infarction in diabetic subjects with and without prior myocardial infarction at base line were 45.0 percent and 20.2 percent, respectively (P<0.001). The hazard ratio for death from coronary heart disease for diabetic subjects without prior myocardial infarction as compared with nondiabetic subjects with prior myocardial infarction was not significantly different from 1.0 (hazard ratio, 1.4; 95 percent confidence interval, 0.7 to 2.6) after adjustment for age and sex, suggesting similar risks of infarction in the two groups. After further adjustment for total cholesterol, hypertension, and smoking, this hazard ratio remained close to 1.0 (hazard ratio, 1.2; 95 percent confidence interval, 0.6 to 2.4).

Conclusions Our data suggest that diabetic patients without previous myocardial infarction have as high a risk of myocardial infarction as nondiabetic patients with previous myocardial infarction. These data provide a rationale for treating cardiovascular risk factors in diabetic patients as aggressively as in nondiabetic patients with prior myocardial infarction.

Source Information

From the Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio (S.M.H.); the Department of Medicine, University of Kuopio, Kuopio, Finland (S.L., K.P., M.L.); and the Department of Medicine, Turku University, Turku, Finland (T.R.).

Address reprint requests to Dr. Haffner at the Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7873.

Full Text of this Article

Related Letters:

Diabetes and Coronary Heart Disease
Simons L. A., Simons J., Engler R. L., McGurk C., Harper R., McCance D. R., Krankenberg H., Lauer B., Schuler G., Haffner S. M., Lehto S., Laakso M.
Extract | Full Text  
N Engl J Med 1998; 339:1714-1716, Dec 3, 1998. Correspondence

This article has been cited by other articles:

• Chung, A. W.Y., Yang, H.H. C., Sigrist, M. K., Brin, G., Chum, E., Gourlay, W. A., Levin, A. (2009). Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res 84: 494-504 [Abstract] [Full Text]  
• Calkin, A. C., Drew, B. G., Ono, A., Duffy, S. J., Gordon, M. V., Schoenwaelder, S. M., Sviridov, D., Cooper, M. E., Kingwell, B. A., Jackson, S. P. (2009). Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux. Circulation 120: 2095-2104 [Abstract] [Full Text]  
• Leibowitz, A., Grossman, E. (2009). How to Define Prehypertension in Diabetes/Metabolic Syndrome. Diabetes Care 32: S275-S279 [Full Text]  
• Nilsson, P. M. (2009). Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?. Diabetes Care 32: S290-S293 [Full Text]  
• Gallwitz, B. (2009). Implications of Postprandial Glucose and Weight Control in People With Type 2 Diabetes: Understanding and implementing the International Diabetes Federation guidelines. Diabetes Care 32: S322-S325 [Full Text]  
• Schnell, O., Otter, W., Standl, E. (2009). The Munich Myocardial Infarction Registry: Translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice. Diabetes Care 32: S326-S330 [Full Text]  
• Conget, I., Gimenez, M. (2009). Glucose Control and Cardiovascular Disease: Is it important? No. Diabetes Care 32: S334-S336 [Full Text]  
• Kassem, S. A., Raz, I. (2009). Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No. Diabetes Care 32: S337-S341 [Full Text]  
• Bianchi, C., Miccoli, R., Daniele, G., Penno, G., Del Prato, S. (2009). Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity/Mortality? Yes. Diabetes Care 32: S342-S348 [Full Text]  
• Rubino, F., Moo, T.-A., Rosen, D. J., Dakin, G. F., Pomp, A. (2009). Diabetes Surgery: A New Approach to an Old Disease. Diabetes Care 32: S368-S372 [Full Text]  
• Kamari, Y., Bitzur, R., Cohen, H., Shaish, A., Harats, D. (2009). Should All Diabetic Patients Be Treated With a Statin?. Diabetes Care 32: S378-S383 [Full Text]  
• Eldor, R., Raz, I. (2009). American Diabetes Association Indications for Statins in Diabetes: Is there evidence?. Diabetes Care 32: S384-S391 [Full Text]  
• Sartoretto, J. L., Jin, B. Y., Bauer, M., Gertler, F. B., Liao, R., Michel, T. (2009). Regulation of VASP phosphorylation in cardiac myocytes: differential regulation by cyclic nucleotides and modulation of protein expression in diabetic and hypertrophic heart. Am. J. Physiol. Heart Circ. Physiol. 297: H1697-H1710 [Abstract] [Full Text]  
• Farkouh, M. E (2009). Review: diabetes is not a coronary disease equivalent. Evid. Based Med. 14: 136-137 [Full Text]  
• Maier, C., Clodi, M., Neuhold, S., Resl, M., Elhenicky, M., Prager, R., Moertl, D., Strunk, G., Luger, A., Struck, J., Pacher, R., Hulsmann, M. (2009). Endothelial Markers May Link Kidney Function to Cardiovascular Events in Type 2 Diabetes. Diabetes Care 32: 1890-1895 [Abstract] [Full Text]  
• Stamatelopoulos, K. S., Kitas, G. D., Papamichael, C. M., Chryssohoou, E., Kyrkou, K., Georgiopoulos, G., Protogerou, A., Panoulas, V. F., Sandoo, A., Tentolouris, N., Mavrikakis, M., Sfikakis, P. P. (2009). Atherosclerosis in Rheumatoid Arthritis Versus Diabetes: A Comparative Study. Arterioscler. Thromb. Vasc. Bio. 29: 1702-1708 [Abstract] [Full Text]  
• van Werkhoven, J M, Gaemperli, O, Schuijf, J D, Jukema, J W, Kroft, L J, Leschka, S, Alkadhi, H, Valenta, I, Pundziute, G, de Roos, A, van der Wall, E E, Kaufmann, P A, Bax, J J (2009). Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood. Heart 95: 1607-1611 [Abstract] [Full Text]  
• Park, J. T., Chang, T. I., Kim, D. K., Lee, J. E., Choi, H. Y., Kim, H. W., Chang, J. H., Park, S. Y., Kim, E., Yoo, T.-H., Han, D.-S., Kang, S.-W. (2009). Metabolic syndrome predicts mortality in non-diabetic patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 0: gfp498v1-gfp498 [Abstract] [Full Text]  
• van Halm, V P, Peters, M J L, Voskuyl, A E, Boers, M, Lems, W F, Visser, M, Stehouwer, C D A, Spijkerman, A M W, Dekker, J M, Nijpels, G, Heine, R J, Bouter, L M, Smulders, Y M, Dijkmans, B A C, Nurmohamed, M T (2009). Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 68: 1395-1400 [Abstract] [Full Text]  
• Bainey, K R, Fu, Y, Granger, C B, Hamm, C W, Holmes, D R Jr, O'Neill, W W, Seabra-Gomes, R, Pfisterer, M E, Van de Werf, F, Armstrong, P W, for the APEX AMI Investigators, (2009). Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?. Heart 95: 1331-1336 [Abstract] [Full Text]  
• Gatti, A., Maranghi, M., Bacci, S., Carallo, C., Gnasso, A., Mandosi, E., Fallarino, M., Morano, S., Trischitta, V., Filetti, S. (2009). Poor Glycemic Control Is an Independent Risk Factor for Low HDL Cholesterol in Patients With Type 2 Diabetes. Diabetes Care 32: 1550-1552 [Abstract] [Full Text]  
• Ueno, H., Koyama, H., Fukumoto, S., Tanaka, S., Shoji, T., Shoji, T., Emoto, M., Tahara, H., Tsujimoto, Y., Tabata, T., Nishizawa, Y. (2009). Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal diseases patients. Nephrol Dial Transplant 0: gfp358v1-gfp358 [Abstract] [Full Text]  
• Nauck, M. A., Ratner, R. E., Kapitza, C., Berria, R., Boldrin, M., Balena, R. (2009). Treatment With the Human Once-Weekly Glucagon-Like Peptide-1 Analog Taspoglutide in Combination With Metformin Improves Glycemic Control and Lowers Body Weight in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Alone: A double-blind placebo-controlled study. Diabetes Care 32: 1237-1243 [Abstract] [Full Text]  
• Matsushima, S., Kinugawa, S., Yokota, T., Inoue, N., Ohta, Y., Hamaguchi, S., Tsutsui, H. (2009). Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am. J. Physiol. Heart Circ. Physiol. 297: H409-H416 [Abstract] [Full Text]  
• Pignone, M. (2009). Screening for Asymptomatic Coronary Artery Disease With Myocardial Perfusion Imaging Does Not Reduce Cardiovascular Events in Middle-Aged and Older Patients With Diabetes. Clin. Diabetes 27: 113-114 [Full Text]  
• Verges, B., Florentin, E., Baillot-Rudoni, S., Petit, J.-M., Brindisi, M. C., Pais de Barros, J.-P., Lagrost, L., Gambert, P., Duvillard, L. (2009). Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes. J. Lipid Res. 50: 1209-1215 [Abstract] [Full Text]  
• Hofsten, D. E., Logstrup, B. B., Moller, J. E., Pellikka, P. A., Egstrup, K. (2009). Abnormal glucose metabolism in acute myocardial infarction influence on left ventricular function and prognosis.. J Am Coll Cardiol Img 2: 592-599 [Abstract] [Full Text]  
• Verhaert, D., Thomas, J. D. (2009). Dysglycemia and acute myocardial infarction the role of echocardiography.. J Am Coll Cardiol Img 2: 600-603 [Full Text]  
• Parving, H.-H., Brenner, B. M., McMurray, John. J. V., de Zeeuw, D., Haffner, S. M., Solomon, S. D., Chaturvedi, N., Ghadanfar, M., Weissbach, N., Xiang, Z., Armbrecht, J., Pfeffer, M. A. (2009). Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Nephrol Dial Transplant 24: 1663-1671 [Abstract] [Full Text]  
• Huhn, R., Heinen, A., Weber, N. C., Kerindongo, R. P., Oei, G. T. M. L., Hollmann, M. W., Schlack, W., Preckel, B. (2009). Helium-Induced Early Preconditioning and Postconditioning Are Abolished in Obese Zucker Rats in Vivo. J. Pharmacol. Exp. Ther. 329: 600-607 [Abstract] [Full Text]  
• Boardman, N., Hafstad, A. D., Larsen, T. S., Severson, D. L., Aasum, E. (2009). Increased O2 cost of basal metabolism and excitation-contraction coupling in hearts from type 2 diabetic mice. Am. J. Physiol. Heart Circ. Physiol. 296: H1373-H1379 [Abstract] [Full Text]  
• Young, L. H., Wackers, F. J. Th., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Heller, G. V., Iskandrian, A. E., Wittlin, S. D., Filipchuk, N., Ratner, R. E., Inzucchi, S. E., for the DIAD Investigators, (2009). Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial. JAMA 301: 1547-1555 [Abstract] [Full Text]  
• O'Connor, P. J., Sperl-Hillen, J. M. (2009). The Role of Diabetes Educators in the Medical Home. Diabetes Spectr. 22: 124-126 [Full Text]  
• Younis, N., Soran, H., Hassanein, M. (2009). Cardiovascular disease and intensive glucose lowering in type 2 diabetes. QJM 102: 293-296 [Full Text]  
• Bergman, A. J., Cote, J., Maes, A., Zhao, J. J., Roadcap, B. A., Sun, L., Valesky, R. J., Yang, A., Keymeulen, B., Mathijs, Z., De Smet, M., Laethem, T., Davies, M. J., Wagner, J. A., Herman, G. A. (2009). Effect of Sitagliptin on the Pharmacokinetics of Simvastatin. J Clin Pharmacol 49: 483-488 [Full Text]  
• Rahman, S., Aziz Al-Safi Ismail, , Shaiful Bahari Ismail, , Nyi Nyi Naing, , Abdul Rashid Abdul Rahman, (2009). Increased arterial stiffness in normoglycaemic offspring of newly diagnosed, never treated type 2 diabetic and impaired glucose tolerance parents. British Journal of Diabetes & Vascular Disease 9: 65-68 [Abstract]  
• Raz, I., Wilson, P. W.F., Strojek, K., Kowalska, I., Bozikov, V., Gitt, A. K., Jermendy, G., Campaigne, B. N., Kerr, L., Milicevic, Z., Jacober, S. J. (2009). Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial. Diabetes Care 32: 381-386 [Abstract] [Full Text]  
• Worm, S. W., De Wit, S., Weber, R., Sabin, C. A., Reiss, P., El-Sadr, W., Monforte, A. D., Kirk, O., Fontas, E., Dabis, F., Law, M. G., Lundgren, J. D., Friis-Moller, N. (2009). Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study). Circulation 119: 805-811 [Abstract] [Full Text]  
• Dagenais, G. R. MD, St-Pierre, A. PhD, Gilbert, P. MD, Lamarche, B. PhD, Despres, J.-P. PhD, Bernard, P.-M. MSc, Bogaty, P. MD (2009). Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. CMAJ 180: 40-47 [Abstract] [Full Text]  
• Bowes, A. J., Khan, M. I., Shi, Y., Robertson, L., Werstuck, G. H. (2009). Valproate Attenuates Accelerated Atherosclerosis in Hyperglycemic ApoE-Deficient Mice: Evidence in Support of a Role for Endoplasmic Reticulum Stress and Glycogen Synthase Kinase-3 in Lesion Development and Hepatic Steatosis. Am. J. Pathol. 174: 330-342 [Abstract] [Full Text]  
• Cosentino, F., Rydén, L., Francia, P., Mellbin, L. G. (2009). CHAPTER 14 Diabetes Mellitus and Metabolic Syndrome. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F. (2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Hiukka, A., Westerbacka, J., Leinonen, E. S., Watanabe, H., Wiklund, O., Hulten, L. M., Salonen, J. T., Tuomainen, T.-P., Yki-Jarvinen, H., Keech, A. C., Taskinen, M.-R. (2008). Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus. J Am Coll Cardiol 52: 2190-2197 [Abstract] [Full Text]  
• Warner, J. J., Weideman, R. A., Kelly, K. C., Brilakis, E. S., Banerjee, S., Cunningham, F., Harford, W. V., Kazi, S., Little, B. B., Cryer, B. (2008). The Risk of Acute Myocardial Infarction with Etodolac Is not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor. J CARDIOVASC PHARMACOL THER 13: 252-260 [Abstract]  
• Authors/Task Force Members, , Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P. G., Tubaro, M., Verheugt, F., Weidinger, F., Weis, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Silber, S., Aguirre, F. V., Al-Attar, N., Alegria, E., Andreotti, F., Benzer, W., Breithardt, O., Danchin, N., Mario, C. D., Dudek, D., Gulba, D., Halvorsen, S., Kaufmann, P., Kornowski, R., Lip, G. Y. H., Rutten, F. (2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. Eur Heart J 29: 2909-2945 [Full Text]  
• Norhammar, A, Stenestrand, U, Lindback, J, Wallentin, L, on behalf of the Register of Information and Knowl, (2008). Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Heart 94: 1565-1570 [Abstract] [Full Text]  
• Duncan, E. R., Crossey, P. A., Walker, S., Anilkumar, N., Poston, L., Douglas, G., Ezzat, V. A., Wheatcroft, S. B., Shah, A. M., Kearney, M. I. (2008). Effect of Endothelium-Specific Insulin Resistance on Endothelial Function In Vivo. Diabetes 57: 3307-3314 [Abstract] [Full Text]  
• Krasuski, R. A. (2008). Primary Prevention and Statins: Is It Just About Going to Class?. Mayo Clin Proc. 83: 1313-1315 [Full Text]  
• Ahanchi, S. S., Varu, V. N., Tsihlis, N. D., Martinez, J., Pearce, C. G., Kapadia, M. R., Jiang, Q., Saavedra, J. E., Keefer, L. K., Hrabie, J. A., Kibbe, M. R. (2008). Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 295: H2388-H2398 [Abstract] [Full Text]  
• McLean, D. L., McAlister, F. A., Johnson, J. A., King, K. M., Makowsky, M. J., Jones, C. A., Tsuyuki, R. T., for the SCRIP-HTN Investigators, (2008). A Randomized Trial of the Effect of Community Pharmacist and Nurse Care on Improving Blood Pressure Management in Patients With Diabetes Mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN). Arch Intern Med 168: 2355-2361 [Abstract] [Full Text]  
• Ogawa, H., Nakayama, M., Morimoto, T., Uemura, S., Kanauchi, M., Doi, N., Jinnouchi, H., Sugiyama, S., Saito, Y., for the Japanese Primary Prevention of Atheroscler, (2008). Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes: A Randomized Controlled Trial. JAMA 300: 2134-2141 [Abstract] [Full Text]  
• Nauck, M. A (2008). Liraglutide, a once-daily human GLP-1 analogue. British Journal of Diabetes & Vascular Disease 8: S26-S33 [Abstract]  
• Rosenstock, J., Hollander, P., Chevalier, S., Iranmanesh, A., for the SERENADE Study Group, (2008). SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes. Diabetes Care 31: 2169-2176 [Abstract] [Full Text]  
• Giorda, C. B., Avogaro, A., Maggini, M., Lombardo, F., Mannucci, E., Turco, S., Alegiani, S. S., Raschetti, R., Velussi, M., Ferrannini, E., for the Diabetes and Informatics Study Group, (2008). Recurrence of Cardiovascular Events in Patients With Type 2 Diabetes: Epidemiology and risk factors. Diabetes Care 31: 2154-2159 [Abstract] [Full Text]  
• Tribouilloy, C, Rusinaru, D, Mahjoub, H, Tartiere, J-M, Kesri-Tartiere, L, Godard, S, Peltier, M (2008). Prognostic impact of diabetes mellitus in patients with heart failure and preserved ejection fraction: a prospective five-year study. Heart 94: 1450-1455 [Abstract] [Full Text]  
• Dasu, M. R., Devaraj, S., Zhao, L., Hwang, D. H., Jialal, I. (2008). High Glucose Induces Toll-Like Receptor Expression in Human Monocytes: Mechanism of Activation. Diabetes 57: 3090-3098 [Abstract] [Full Text]  
• Cade, W T. (2008). Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. ptjournal 88: 1322-1335 [Abstract] [Full Text]  
• Mzhavia, N., Yu, S., Ikeda, S., Chu, T. T., Goldberg, I., Dansky, H. M. (2008). Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice. Diabetes 57: 2774-2783 [Abstract] [Full Text]  
• Khanderia, U., Pop-Busui, R., Eagle, K. A (2008). Thiazolidinediones in Type 2 Diabetes: A Cardiology Perspective. The Annals of Pharmacotherapy 42: 1466-1474 [Abstract] [Full Text]  
• Kilpatrick, E S (2008). Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J. Clin. Pathol. 61: 977-982 [Abstract] [Full Text]  
• Hartman, I. (2008). Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence. Clin Med Res 6: 54-67 [Abstract] [Full Text]  
• Zaman Huri, H., Lee Qiu Yi, , Pendek, R., Che Zuraini Sulaiman, (2008). Use of Antiplatelet Agents for Primary and Secondary Prevention of Cardiovascular Disease Amongst Type 2 Diabetic Patients. Journal of Pharmacy Practice 21: 287-301 [Abstract]  
• Nicholls, S. J., Tuzcu, E. M., Kalidindi, S., Wolski, K., Moon, K.-W., Sipahi, I., Schoenhagen, P., Nissen, S. E. (2008). Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling: A Pooled Analysis of 5 Intravascular Ultrasound Trials. J Am Coll Cardiol 52: 255-262 [Abstract] [Full Text]  
• White, J. R. Jr (2008). Do People With Diabetes Need Statins?. The Diabetes Educator 34: 664-673 [Abstract] [Full Text]  
• Roelker, E. (2008). Screening for Coronary Artery Disease in Patients With Diabetes. Diabetes Spectr. 21: 166-171 [Abstract] [Full Text]  
• Triplitt, C., Alvarez, C. A. (2008). Best Practices for Lowering the Risk of Cardiovascular Disease in Diabetes. Diabetes Spectr. 21: 177-189 [Abstract] [Full Text]  
• Saudek, C. D., Herman, W. H., Sacks, D. B., Bergenstal, R. M., Edelman, D., Davidson, M. B. (2008). A New Look at Screening and Diagnosing Diabetes Mellitus. J. Clin. Endocrinol. Metab. 93: 2447-2453 [Abstract] [Full Text]  
• Shishido, T., Woo, C.-H., Ding, B., McClain, C., Molina, C. A., Yan, C., Yang, J., Abe, J.-i. (2008). Effects of MEK5/ERK5 Association on Small Ubiquitin-Related Modification of ERK5: Implications for Diabetic Ventricular Dysfunction After Myocardial Infarction. Circ. Res. 102: 1416-1425 [Abstract] [Full Text]  
• van der Meer, R. W., Rijzewijk, L. J., Diamant, M., Hammer, S., Schar, M., Bax, J. J., Smit, J. W.A., Romijn, J. A., de Roos, A., Lamb, H. J. (2008). The ageing male heart: myocardial triglyceride content as independent predictor of diastolic function. Eur Heart J 29: 1516-1522 [Abstract] [Full Text]  
• Wassink, A. M., Van Der Graaf, Y., Soedamah-Muthu, S. S, Spiering, W., Visseren, F. L. (2008). Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diabetes and Vascular Disease Research 5: 114-122 [Abstract]  
• Burdon, K. P, Lehtinen, A. B, Langefeld, C. D, Carr, J. J., Rich, S. S, Freedman, B. I, Herrington, D., Bowden, D. W (2008). Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diabetes and Vascular Disease Research 5: 128-134 [Abstract]  
• Natarajan, A., Zaman, A. G, Marshall, S. M (2008). Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents. Diabetes and Vascular Disease Research 5: 138-144 [Abstract]  
• Bloomgarden, Z. T. (2008). Cardiovascular Disease in Diabetes. Diabetes Care 31: 1260-1266 [Full Text]  
• Goldberg, I. J., Hu, Y., Noh, H.-L., Wei, J., Huggins, L. A., Rackmill, M. G., Hamai, H., Reid, B. N., Blaner, W. S., Huang, L.-S. (2008). Decreased Lipoprotein Clearance Is Responsible for Increased Cholesterol in LDL Receptor Knockout Mice With Streptozotocin-Induced Diabetes. Diabetes 57: 1674-1682 [Abstract] [Full Text]  
• Karalliedde, J., Smith, A., DeAngelis, L., Mirenda, V., Kandra, A., Botha, J., Ferber, P., Viberti, G. (2008). Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering. Hypertension 51: 1617-1623 [Abstract] [Full Text]  
• Mauldin, J. P., Nagelin, M. H., Wojcik, A. J., Srinivasan, S., Skaflen, M. D., Ayers, C. R., McNamara, C. A., Hedrick, C. C. (2008). Reduced Expression of ATP-Binding Cassette Transporter G1 Increases Cholesterol Accumulation in Macrophages of Patients With Type 2 Diabetes Mellitus. Circulation 117: 2785-2792 [Abstract] [Full Text]  
• Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., Hong, Y. (2008). Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 117: 2544-2565 [Abstract] [Full Text]  
• Lund, S. S, Tarnow, L., Stehouwer, C. D A, Schalkwijk, C. G, Teerlink, T., Gram, J., Winther, K., Frandsen, M., Smidt, U. M, Pedersen, O., Parving, H.-H., Vaag, A. A (2008). Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes. Eur J Endocrinol 158: 631-641 [Abstract] [Full Text]  
• Davidson, M., Meyer, P. M., Haffner, S., Feinstein, S., D'Agostino, R. Sr, Kondos, G. T., Perez, A., Chen, Z., Mazzone, T. (2008). Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus. Circulation 117: 2123-2130 [Abstract] [Full Text]  
• Goldfine, A. B., Beckman, J. A. (2008). Life and Death in Denmark: Lessons About Diabetes and Coronary Heart Disease. Circulation 117: 1914-1917 [Full Text]  
• Schramm, T. K., Gislason, G. H., Kober, L., Rasmussen, S., Rasmussen, J. N., Abildstrom, S. Z., Hansen, M. L., Folke, F., Buch, P., Madsen, M., Vaag, A., Torp-Pedersen, C. (2008). Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk: A Population Study of 3.3 Million People. Circulation 117: 1945-1954 [Abstract] [Full Text]  
• Betteridge, D. J., DeFronzo, R. A., Chilton, R. J. (2008). PROactive: time for a critical appraisal. Eur Heart J 29: 969-983 [Abstract] [Full Text]  
• Nissen, S. E., Nicholls, S. J., Wolski, K., Nesto, R., Kupfer, S., Perez, A., Jure, H., De Larochelliere, R., Staniloae, C. S., Mavromatis, K., Saw, J., Hu, B., Lincoff, A. M., Tuzcu, E. M., for the PERISCOPE Investigators, (2008). Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes: The PERISCOPE Randomized Controlled Trial. JAMA 299: 1561-1573 [Abstract] [Full Text]  
• BAKHRU, M. R., BHATT, D. L. (2008). INTERPRETING THE CHARISMA STUDY: What is the role of dual antiplatelet therapy with clopidogrel and aspirin?. Cleveland Clinic Journal of Medicine 75: 289-295 [Abstract] [Full Text]  
• Fowler, M. J. (2008). Microvascular and Macrovascular Complications of Diabetes. Clin. Diabetes 26: 77-82 [Full Text]  
• Rossi, M. C.E., Nicolucci, A., Pellegrini, F., Comaschi, M., Ceriello, A., Cucinotta, D., Giorda, C., Valentini, U., Vespasiani, G., De Cosmo, S. (2008). Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 23: 1278-1284 [Abstract] [Full Text]  
• Nasu, K, Tsuchikane, E, Katoh, O, Fujita, H, Surmely, J-F, Ehara, M, Kinoshita, Y, Tanaka, N, Matsubara, T, Asakura, Y, Asakura, K, Terashima, M, Suzuki, T (2008). Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart 94: 429-433 [Abstract] [Full Text]